Recycling     Contact Us     My Account     Login     Logout
Language:
English Español Deutsch
Currency:
My Cart
0 Items
    PRODUCT CATEGORIES
    SynTissue™ Components
    SynTissue™ Sample Kits
    SynTissue™ Tissue Plates
    SynDaver™ Arteries
    SynDaver™ Veins
    SynDaver™ Bones
    SynDaver™ Joints
    SynDaver™ Limbs
    SynDaver™ Muscles
    SynDaver™ Organs
    SynDaver™ Pathology
    Medical Education
    Pumps and Tanks
    Electronic Parts
    Miscellaneous
    ABOUT US
Background
SynDaver™ Labs was founded in 2004 to commercialize a novel system of synthetic human tissues and body parts for the medical device industry. The company's growing portfolio of SynDaver™ and SynTissue™ brand simulation products includes sophisticated models that replicate human anatomy in unprecedented detail, including individual muscles, tendons, veins, arteries, and organs, all made from synthetic materials that mimic the properties of live tissue. These products are used by medical manufacturers to replace live animals in design studies, by medical staff in clinical training and surgical simulation, and by military developers of armor systems.

Technology
Our company's simulation products are manufactured from a library of proprietary synthetic materials that mimic the properties of live tissue. The initial work on this ground breaking technology was started by Dr. Christopher Sakezles at the University of Florida in 1991. By early 1993 his synthetic human trachea models were being used at the university to replace live animals in the testing of new endotracheal tubes, and to this day they are among the most advanced organ models ever made. In 1996 Dr. Sakezles began developing a series of synthetic human tissues and body parts for use in the testing of various medical devices. These technologies are covered in the U.S. and internationally by issued and pending patents.

Focus
The FDA requires simulated use testing for medical products that are intended for use on humans, a mandate historically interpreted by developers as a requirement to perform animal studies. However, our firm is dedicated to providing economically viable alternatives to such testing where possible, and we are actively developing new technologies to satisfy this need. The focus of this effort is not to prevent animal use, but rather to provide industry with new tools to improve test data integrity, enhance device safety, reduce time to market, and minimize risk.

Media
Medical Product Manufacturing News, Medical Device Technology Magazine, Sarasota Business Magazine, Gulf Coast Business Review, Sarasota Herald-Tribune, Tampa Bay Business Journal, The Maddux Report, U.S. Department of Commerce Innovation Award, Technology White Paper, Simple Medical Device Study, US Patent No 7272766, US Patent No 7427199, US Patent No 7507092.
Copyright © 2005 - 2010 SynDaver™ Labs, All Rights Reserved. Privacy Policy - Purchase Policy - Terms of Use.